These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 30287151)

  • 21. Effect of combination therapy with angiotensin receptor blocker and 1,25-dihydroxyvitamin D(3) in type 2 diabetic nephropathy in KK-A(y)/Ta mice.
    Ohara I; Tanimoto M; Gohda T; Yamazaki T; Hagiwara S; Murakoshi M; Aoki T; Toyoda H; Ishikawa Y; Funabiki K; Horikoshi S; Tomino Y
    Nephron Exp Nephrol; 2011; 117(4):e124-32. PubMed ID: 20948237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term, high-dosage candesartan suppresses inflammation and injury in chronic kidney disease: nonhemodynamic renal protection.
    Yu C; Gong R; Rifai A; Tolbert EM; Dworkin LD
    J Am Soc Nephrol; 2007 Mar; 18(3):750-9. PubMed ID: 17287430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjunctive therapy with statins reduces residual albuminuria/proteinuria and provides further renoprotection by downregulating the angiotensin II-AT1 pathway in hypertensive nephropathy.
    Zhang Z; Li Z; Cao K; Fang D; Wang F; Bi G; Yang J; He Y; Wu J; Wei Y; Song X
    J Hypertens; 2017 Jul; 35(7):1442-1456. PubMed ID: 28244896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of addition of silymarin to renin-angiotensin system inhibitors on proteinuria in type 2 diabetic patients with overt nephropathy: a randomized, double-blind, placebo-controlled trial.
    Fallahzadeh MK; Dormanesh B; Sagheb MM; Roozbeh J; Vessal G; Pakfetrat M; Daneshbod Y; Kamali-Sarvestani E; Lankarani KB
    Am J Kidney Dis; 2012 Dec; 60(6):896-903. PubMed ID: 22770926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local delivery of angiotensin II receptor blockers into the kidney passively attenuates inflammatory reactions during the early phases of streptozotocin-induced diabetic nephropathy through inhibition of calpain activity.
    Kamal F; Yanakieva-Georgieva N; Piao H; Morioka T; Oite T
    Nephron Exp Nephrol; 2010; 115(3):e69-79. PubMed ID: 20424485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteinuria-lowering effect of heparin therapy in diabetic nephropathy without affecting the renin-angiotensin-aldosterone system.
    Benck U; Haeckel S; Clorius JH; van der Woude FJ
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):58-67. PubMed ID: 17699388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
    Katavetin P; Eiam-Ong S; Suwanwalaikorn S
    J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin D and Diabetic Kidney Disease.
    Huang HY; Lin TW; Hong ZX; Lim LM
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetic nephropathy and multiorgan protection. Part II.
    Gluhovschi G; Gluhovschi C; Vlad A; Timar R; Bob F; Velciov S; Bozdog G; Petrica L
    Rom J Intern Med; 2011; 49(4):237-49. PubMed ID: 22568268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats.
    Kato S; Luyckx VA; Ots M; Lee KW; Ziai F; Troy JL; Brenner BM; MacKenzie HS
    Kidney Int; 1999 Sep; 56(3):1037-48. PubMed ID: 10469372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comment on: The current practice of using angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in diabetic hypertensive and non-hypertensive patients. Is there a room for vitamin D?
    Alsaeed A
    Saudi Med J; 2021 Jan; 42(1):115. PubMed ID: 33399181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of dual blockade of the renin-angiotensin system on the progression of type 2 diabetic nephropathy: a randomized trial.
    Fernandez Juarez G; Luño J; Barrio V; de Vinuesa SG; Praga M; Goicoechea M; Cachofeiro V; Nieto J; Fernández Vega F; Tato A; Gutierrez E;
    Am J Kidney Dis; 2013 Feb; 61(2):211-8. PubMed ID: 22939518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Emerging Role of Vitamin D and Vitamin D Receptor in Diabetic Nephropathy.
    Lei M; Liu Z; Guo J
    Biomed Res Int; 2020; 2020():4137268. PubMed ID: 32766307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The current practice of using angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in diabetic hypertensive and non-hypertensive patients. Is there a room for vitamin D?
    Sukkarieh HH; Bustami RT; Abdu MN; Khokhar AA; Salih AA; Abdalla HK
    Saudi Med J; 2020 Oct; 41(10):1083-1089. PubMed ID: 33026049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of aspirin with telmisartan suppresses the augmented TGFbeta/smad signaling during the development of streptozotocin-induced type I diabetic nephropathy.
    Mulay SR; Gaikwad AB; Tikoo K
    Chem Biol Interact; 2010 Apr; 185(2):137-42. PubMed ID: 20223228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition.
    Kim MJ; Frankel AH; Donaldson M; Darch SJ; Pusey CD; Hill PD; Mayr M; Tam FW
    Kidney Int; 2011 Oct; 80(8):851-60. PubMed ID: 21832985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal effects of dual renin-angiotensin-aldosterone system blockade in patients with diabetic nephropathy.
    Dalla Vestra M; Simioni N; Masiero A
    Int Urol Nephrol; 2009; 41(1):119-26. PubMed ID: 18958580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease.
    Song JH; Cha SH; Lee HJ; Lee SW; Park GH; Lee SW; Kim MJ
    Nephrol Dial Transplant; 2006 Mar; 21(3):683-9. PubMed ID: 16330466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin D analogues to target residual proteinuria: potential impact on cardiorenal outcomes.
    Humalda JK; Goldsmith DJ; Thadhani R; de Borst MH
    Nephrol Dial Transplant; 2015 Dec; 30(12):1988-94. PubMed ID: 25609737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in Rats.
    Zhao T; Sun S; Zhang H; Huang X; Yan M; Dong X; Wen Y; Wang H; Lan HY; Li P
    PLoS One; 2016; 11(1):e0147693. PubMed ID: 26807792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.